This stock is just starting to move, Proffetti. Top line data in the next few days or weeks for a cancer treatment that literally has no side effects and is applicable to all solid cancers....though this clinical trial is only for GBM, the toughest or the tough cancers to cure. Other cancers will be label extensions, most likely. Ovarian cancer Phase I Clinical trial already completed. Much more. Check out my posts from yesterday. Welcome to the board.
News 
Market Data 
Discover 
